
Embecta Investor Relations Material
Latest events

Investor Day 2025
Embecta
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Embecta Corp
Access all reports
Embecta Corp is a medical technology company focused on the development and manufacturing of diabetes care products. The company specializes in providing devices and solutions for insulin delivery, including insulin syringes and pen needles, aimed at improving the daily management of diabetes. Embecta serves healthcare providers and patients globally, with a mission to support individuals with diabetes in maintaining their health through reliable and accessible products. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Key slides for Embecta Corp


43rd Annual J.P. Morgan Healthcare Conference 2025
Embecta Corp


Investor Day 2025
Embecta Corp
Latest articles
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
)
Costco Wholesale: The Model of Scalable Simplicity
Costco's rise from warehouse club to retail giant is built on low prices, scale efficiency, and a model designed for lasting customer value.
26 May 2025
Ticker symbol
EMBC
Country
🇺🇸 United States